Stewart Hackney, Mhrd
About Stewart Hackney, Mhrd
Stewart Hackney, MHRD, serves as the Senior Director of GPO/Physician Networks, Field Reimbursement, and Payer National Accounts at Geron Corporation. With extensive experience in the pharmaceutical industry, he has held various leadership roles at companies such as Seagen, Novartis, and Merck, focusing on oncology and market access.
Current Role at Geron Corporation
Stewart Hackney serves as the Senior Director of GPO/Physician Networks, Field Reimbursement, and Payer National Accounts at Geron Corporation. He has held this position since 2023, working remotely from Parsippany, New Jersey. In this role, he is responsible for managing relationships with group purchasing organizations and physician networks, as well as overseeing reimbursement strategies and national account management.
Previous Experience at Seagen
Prior to joining Geron, Stewart Hackney worked at Seagen for two years, from 2021 to 2023. He held the position of Director of Global Value & Access Innovation, where he focused on developing strategies to enhance market access for oncology products. He also served as Associate Director of Global Value & Access GPO/Physician Networks at Seagen from 2019 to 2021, contributing to the company's initiatives in value-based care.
Career Background in Oncology Sales
Stewart Hackney has extensive experience in oncology sales and market access, having worked with several major pharmaceutical companies. His tenure at Merck included roles such as Sr. Manager of Oncology Key Accounts and Oncology GPO National Account Director. He also held various positions at Novartis, including Sr. Sales Specialist in Biologics/Immunotherapy and District Sales Manager for Specialty Medicines.
Educational Background and Specializations
Stewart Hackney earned a Master of Science in Organizational Design and Human Resources Development from Clemson University, where he studied from 2014 to 2018. He also completed a Preceptorship in Solid Tumor Biology at Washington University in St. Louis in 2002 and a Preceptorship in Respiratory Disease at Harvard Medical School in 2005. He holds a Bachelor of Science in Business Administration from Presbyterian College, obtained from 1992 to 1996.
Expertise in Oncology Market Access
Stewart Hackney possesses expertise in ImmunoOncology and ADC Therapeutics, which are significant areas in cancer treatment. He has a comprehensive understanding of Oncology Market Access, including payer policy, patient support, and reimbursement strategies. His experience includes building pre-commercial infrastructure for novel Oncolytic product launches, demonstrating his commitment to improving patient outcomes through innovative healthcare solutions.